Dow Jones Futures: ຕະຫຼາດ Rally ແລ່ນໄປສູ່ການຕໍ່ຕ້ານທີ່ສໍາຄັນ; 5 ຮຸ້ນ Flash ຊື້ສັນຍານ

Dow Jones futures tilted higher overnight, along with S&P 500 futures and Nasdaq futures, with Zscaler (ZS) ແລະ DocuSign (DOCU) among the notable earnings report. The stock market rally was up and down on Thursday, ultimately closing near session highs, setting up a big test of their 50-day moving averages.

X

ຊີວະວິທະຍາ Neurocrine (NBIX), ຢາ Vertex (VRTX), BioMarin Pharmaceuticals (BMRN), Centene (Cnc) ແລະ Axonics (AXNX) flashed buy signals Thursday.

But while these five stocks are leading the market, they are not independent from it. NBIX stock and Vertex were still actionable at the close, but came off intraday highs as the indexes whipsawed off their best levels. Centene stock backed off, and may need a little more strength. BMRN stock showed strong action, closing high in the day’s range, but in light volume. Only AXNX stock closed with a truly strong advance, and that came on news of an Axonics product milestone.

ກ່ຽວກັບຈຸດອ່ອນ, ຈາກຫນາກແອບເປີ (AAPL) retreated a day after edging higher on the new iPhone 14 and other products. Megacaps are lagging in the current market environment, with all trading below their 200-day moving averages. Tesla (TSLA) is the only way making a real move toward the 200-day right now.

After the market close, cybersecurity firm Zscaler and documents software specialist DocuSign reported ດີກວ່າທີ່ຄາດໄວ້ ຜົນໄດ້ຮັບປະ ຈຳ ໄຕມາດ and gave solid guidance. ZS stock popped overnight, while DOCU stock soared. The former leaders are far below highs and nowhere near actionable, but the reports are a good sign for software stocks and IT spending.

NBIX stock and Vertex Pharmaceuticals are on ກະດານຈັດອັນດັບ IBD. Tesla stock and Axonics are on the IBD 50. ຮຸ້ນ VRTX ແມ່ນຢູ່ໃນ IBD Big Cap 20.

Dow Jones Futures ມື້ນີ້

Dow Jones ໃນອະນາຄົດເພີ່ມຂື້ນ 0.1% ທຽບກັບມູນຄ່າຍຸດຕິ ທຳ. S&P 500 ໃນອະນາຄົດໄດ້ເພີ່ມຂື້ນ 0.15%. Nasdaq 100 futures ກ້າວ ໜ້າ 0.2%.

ຈື່ໄວ້ວ່າການປະຕິບັດຄືນໃນ Dowures ໃນອະນາຄົດ ແລະບ່ອນອື່ນບໍ່ຈໍາເປັນຕ້ອງແປເປັນການຊື້ຂາຍຕົວຈິງໃນປົກກະຕິຕໍ່ໄປ ຕະ​ຫຼາດ​ຫຸ້ນ session

ເຂົ້າຮ່ວມຊ່ຽວຊານຂອງ IBD ໃນຂະນະທີ່ພວກເຂົາວິເຄາະຮຸ້ນທີ່ມີການເຄື່ອນໄຫວໃນການຊຸມນຸມຂອງຕະຫລາດຫຸ້ນໃນ IBD Live

ການເຕົ້າໂຮມຕະຫລາດຫຸ້ນ

The stock market rally had an up-and-down session, selling off near the open, rebounding for solid gains, and going back and forth before finally advancing with decent gains after Wednesday’s strong rebound.

Just before the market open, Fed chief Jerome Powell reiterated that he is “strongly committed” to fighting inflation, reinforcing expectations for a third straight 75-basis-point rate hike on Sept. 21. Shortly before that, the European Central Bank raised its key rate by 75 basis points. Later on, ECB sources hinted that another 75 basis points could come in October.

Meanwhile, initial jobless claims defied forecasts, falling for a fourth straight week, sending yet another signal to Fed chief Powell that labor markets are still very tight.

The Dow Jones Industrial Average and Nasdaq composite rose 0.6% in Thursday’s ການຊື້ຂາຍໃນຕະຫຼາດຫຸ້ນ. The S&P 500 index gained 0.7%. The small-cap Russell 2000 led with a 0.8% advance.

U.S. crude oil prices rose 2% to $83,54 a barrel after tumbling to their lowest levels since January on Wednesday.

ຜົນຜະລິດຄັງເງິນ 10 ປີເພີ່ມຂຶ້ນ 3 ຈຸດພື້ນຖານເປັນ 3.29%.

ໃນບັນດາ ETFs ທີ່ດີທີ່ສຸດ, ຜູ້ປະດິດສ້າງ IBD 50 ETF (FFTY) ເພີ່ມຂຶ້ນ 1.5%, ໃນຂະນະທີ່ Innovator IBD Breakout Opportunities ETF (ສິ້ນສຸດ) ເພີ່ມຂຶ້ນ 1%. The iShares Expanded Tech-Software Sector ETF (IGV) ແລະ VanEck Vectors Semiconductor ETF (SMH) ເພີ່ມຂຶ້ນ 1.4%.

SPDR S&P Metals & Mining ETF (XME) ເພີ່ມຂຶ້ນ 0.6%. ພະລັງງານເລືອກ SPDR ETF (XLE) ກ້າວຫນ້າ 0.4% ແລະ Financial Select SPDR ETF (XLF) 1.8%. ກອງທຶນດູແລສຸຂະພາບເລືອກຂະແໜງ SPDR (XLIV) gained 1.7%. CNC stock and Vertex are XLV components.

ສະທ້ອນໃຫ້ເຫັນເຖິງຮຸ້ນເລື່ອງທີ່ຄາດເດົາຫຼາຍຂຶ້ນ, ARK Innovation ETF (ARKK) ເພີ່ມຂຶ້ນ 3% ແລະ ARK Genomics ETF (ARKG) 3.6%. ຫຼັກຊັບ Tesla ແມ່ນການຖືຄອງທີ່ສໍາຄັນໃນທົ່ວ ETFs ຂອງ Ark Invest.

ຫ້າຫຸ້ນທີ່ດີທີ່ສຸດຂອງຈີນເພື່ອເບິ່ງດຽວນີ້

ຫຸ້ນ Apple

Apple stock fell 1% to 154.45 on Thursday. Shares hit their lowest levels since late July. The ເສັ້ນຄວາມເຂັ້ມແຂງພີ່ນ້ອງ is now quickly declining after record highs as recently as Aug. 17. As the most-valuable U.S.-listed company and a member of the Dow Jones, S&P 500 and Nasdaq composite, if AAPL stock is declining, it’s hard for the major indexes to make much headway. The other megacap stocks also are struggling.

Tesla ຫຸ້ນ

Tesla stock is a partial exception to the megacap malaise, rising nearly 2% to 289.26. It’s now up 7% this week, rebounding from its 50-day moving average. But this week’s gains have come in weak volume. And TSLA stock remains below its declining 200-day line. A decisive move above the 200-day line, perhaps clearing the 300 level or the Aug. 14 high of 314.64, would offer an early entry.

Tesla Vs. BYD: EV Giant ອັນໃດແມ່ນການຊື້ທີ່ດີກວ່າ?

ການວິເຄາະການລວບລວມຕະຫລາດ

The stock market rally shrugged off early solid losses, unwilling to give up Wednesday’s big gains. Despite some numerous swings intraday, the major indexes all closed near session highs.

After appearing to hit resistance at their morning highs, the S&P 500 and Russell 2000 finished just below their 50-day moving averages. Keeping in mind that the S&P 500 came within one point of its 200-day line on Aug. 16 — with the small-cap Russell just above the level — marking the top of the current rally. On Sept. 2, the S&P 500 and Russell 2000 touched their 50-day line and then reversed hard.

So the 50-day moving average isn’t just a line on a chart. Moving decisively above that level would be a bullish sign. Note that the 21-day moving average is racing down toward the 50-day for all the key indexes.

Above those lines, a market rally might have a little room to run, but the 200-day average would be the ultimate test.

Investors should follow the market primarily by the major indexes and leading stocks. In recent days, leading stocks have looked better than the major indexes.

But Neurocrine, Centene and Vertex came off highs as the market initially hit resistance, even with the Nasdaq, S&P 500 and Dow Jones closing near Thursday’s best levels. If the major indexes head south again, most stocks will follow suit.

Solar and pollution control stocks are doing well. So are a wide variety of medical names from the biotech, products/systems and health insurers. Lithium plays are running hot, but volatile charts make them hard to handle.

A few tech names setting up but generally aren’t flashing buy signals yet. But continued market strength could see techs triggering buy points, along with stocks from a variety of sectors.

It’s OK if megacap stocks like Apple aren’t leading a market uptrend, but it would be healthy for some of them to be actively participating.

ເວລາຕະຫຼາດດ້ວຍຍຸດທະສາດການຕະຫຼາດ ETF ຂອງ IBD

ສິ່ງທີ່ຕ້ອງເຮັດໃນປັດຈຸບັນ

More stocks are flashing buy signals, at least intraday. So it’s understandable if investors chose to nibble on some new positions, aiming to get an early ticket on some big runs.

Remember that with the major indexes so close to their 50-day lines, taking on a new position becomes even riskier — unless and until the major indexes decisively break higher. So consider taking small positions, at least to start, and be ready to take quick profits and cut losses ruthlessly.

If you pass on taking new positions for now, there will be other buying opportunities if the market gains momentum. A large number of stocks are close to being actionable, or close to being close.

So work on your watchlists. Stay alert and be nimble.

ອ່ານ ຮູບໃຫຍ່ ທຸກໆມື້ເພື່ອໃຫ້ສອດຄ່ອງກັບທິດທາງຕະຫຼາດແລະຫຼັກຊັບແລະຂະແຫນງການຊັ້ນນໍາ.

ກະລຸນາຕິດຕາມ Ed Carson ໃນ Twitter ທີ່ @IBD_ECarson ສຳ ລັບການປັບປຸງຕະຫຼາດຫຸ້ນແລະອື່ນໆ.

ທ່ານອາດຈະມັກ:

ຈັບຫຸ້ນໃຫຍ່ທີ່ມີໄຊຊະນະໃຫຍ່ຕໍ່ໄປດ້ວຍ MarketSmith

ຕ້ອງການທີ່ຈະໄດ້ຮັບຜົນ ກຳ ໄລໂດຍໄວແລະຫລີກລ້ຽງການສູນເສຍທີ່ໃຫຍ່? ລອງໃຊ້ SwingTrader

ຫຼັກຊັບການເຕີບໂຕທີ່ດີທີ່ສຸດທີ່ຈະຊື້ແລະເບິ່ງ

IBD Digital: ປົດລLອກລາຍຊື່ຮຸ້ນທີ່ນິຍົມຂອງ IBD, ເຄື່ອງມືແລະການວິເຄາະໃນມື້ນີ້